Mayo risk score and outcome of liver transplantation in primary biliary cirrhosis: A report from the second decade.

被引：0
作者：
Kim, WR
Malinchoc, M
Therneau, TM
Crippin, JS
Klintmalm, GBG
Krom, RAF
Wiesner, RH
Dickson, ER
机构：
[1] MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA
[2] BAYLOR UNIV, DALLAS, TX USA
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1302 / A1302
页数：1
相关论文
共 50 条
[1]   Optimal timing and outcome of liver transplantation in primary biliary cirrhosis using Mayo risk score: An experience from the second decade. [J].
Vinayek, R ;
Balan, V ;
Shakil, O ;
AbuElmagd, K ;
Irish, W ;
McMichael, J ;
Fung, JJ ;
Rakela, J .
HEPATOLOGY, 1997, 26 (04) :141-141
[2]   Mayo risk score for primary biliary cirrhosis: A useful tool for the prediction of course after liver transplantation? [J].
Jacob, DietmarA. ;
Bahra, Marcus ;
Schmidt, Sven C. ;
Schumacher, Guido ;
Weimann, Andreas ;
Neuhaus, Peter ;
Neumann, Ulf P. .
ANNALS OF TRANSPLANTATION, 2008, 13 (03) :35-42
[3]   Atorvastatin Does Not Improve Liver Biochemistries or Mayo Risk Score in Primary Biliary Cirrhosis [J].
Carmen M. Stanca ;
Nancy Bach ;
Jorge Allina ;
Carol Bodian ;
Henry Bodenheimer ;
Joseph A. Odin .
Digestive Diseases and Sciences, 2008, 53 :1988-1993
[4]   Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis [J].
Stanca, Carmen M. ;
Bach, Nancy ;
Allina, Jorge ;
Bodian, Carol ;
Bodenheimer, Henry, Jr. ;
Odin, Joseph A. .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) :1988-1993
[5]   PRIMARY BILIARY-CIRRHOSIS TRIALS AND MAYO RISK SCORE [J].
HENLEY, KS .
GASTROENTEROLOGY, 1994, 107 (05) :1570-1570
[6]   Confirmation of the role of the Mayo risk score as a predictor of resource utilization after orthotopic liver transplantation for primary biliary cirrhosis [J].
Gilroy, RK ;
Lynch, SV ;
Strong, RW ;
Kerlin, P ;
Balderson, GA ;
Stuart, KA ;
Crawford, DHG .
LIVER TRANSPLANTATION, 2000, 6 (06) :749-752
[7]   Mayo risk score accurately predicts patient outcome with ursodeoxycholic acid treatment of primary biliary cirrhosis. [J].
Lindor, KD ;
Therneau, TM ;
Hermans, JE ;
Dickson, ER .
HEPATOLOGY, 1996, 24 (04) :164-164
[8]   Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid [J].
Angulo, P ;
Lindor, KD ;
Therneau, TM ;
Jorgensen, RA ;
Malinchoc, M ;
Kamath, PS ;
Dickson, ER .
LIVER, 1999, 19 (02) :115-121
[9]   COMPARISON OF LIVER TRANSPLANTATION OUTCOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, PRIMARY BILIARY CIRRHOSIS, AND SECONDARY BILIARY CIRRHOSIS [J].
Sogawa, Hiroshi ;
Arnon, Ronen ;
Annunziato, Rachel A. ;
Miloh, Tamir A. ;
Schiano, Thomas D. .
HEPATOLOGY, 2010, 52 (04) :484A-484A
[10]   Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence [J].
Neuberger, J .
JOURNAL OF HEPATOLOGY, 2003, 39 (02) :142-148
12345